Tenofovir DF ring protects macaques from vaginal exposure
1 April 2013. Related: Conference reports, HIV prevention and transmission.
HIV prevention and transmission
VOICE study reports low adherence as reason for lack of efficacy for PrEP: anal sex common in African heterosexuals
1 April 2013. Related: Conference reports, HIV prevention and transmission.
Further studies on how male circumcision may reduce HIV transmission
1 April 2013. Related: Conference reports, HIV prevention and transmission.
Minimal risk of sexual HIV transmission for heterosexual couples when the HIV positive partner has an undetectable viral load
1 February 2013. Related: Conference reports, Women's health, HIV prevention and transmission.
UK group describe risk of HIV transmission for people on effective ART as “extremely low”
1 February 2013. Related: HIV prevention and transmission.
CDC issues brief on the prevention benefits of HIV treatment
1 February 2013. Related: HIV prevention and transmission.
WHO recommendations for prevention and treatment of HIV for sex workers and their clients
1 February 2013. Related: HIV prevention and transmission.
Quantifying HIV-1 exposure to illuminate resistance to infection
1 December 2012. Related: HIV prevention and transmission.
Immune activation, inflammation and HIV acquisition risk
1 December 2012. Related: HIV prevention and transmission.
HPTN-052: clinical advantages from earlier treatment
1 October 2012. Related: Conference reports, Antiretrovirals, HIV prevention and transmission.
Online video interviews between researchers and activists
1 October 2012. Related: Conference reports, Antiretrovirals, Treatment access, HIV prevention and transmission, Cure-related research, Other news.
High levels of maraviroc in rectal tissue fail to protect macaques from SIV transmission following rectal exposure
1 August 2012. Related: Conference reports, HIV prevention and transmission.
Mechanisms for circumcision to reduce HIV transmission in different penile tissue: target cell differences rather than keratinisation
1 August 2012. Related: Conference reports, HIV prevention and transmission.
FDA approve Truvada to reduce the risk of sexual transmission
1 August 2012. Related: HIV prevention and transmission.
Half of gay men in London would chose oral PrEP to reduce risk of HIV
1 June 2012. Related: Conference reports, HIV prevention and transmission.
Recent infection is common in UK; 30% gay men aged 15-25 infected within a year of diagnosis
1 June 2012. Related: Conference reports, HIV prevention and transmission.
3rd vs 4th generation HIV testing: almost half of UK clinics out of step with national guidelines
1 June 2012. Related: Conference reports, HIV prevention and transmission.
WHO guidelines for testing, counselling and treatment in serodifferent couples (April 2012): ART at CD4 >350 to reduce transmission
1 June 2012. Related: Guidelines, HIV prevention and transmission.
NICE guideline on fertility treatment proposes alternatives to sperm washing (2012)
1 June 2012. Related: Guidelines, HIV prevention and transmission.
Early data for rilpivirine long acting formulation supports further investigation for PrEP
1 June 2012. Related: Conference reports, Antiretrovirals, HIV prevention and transmission.
PrEP: PK modeling of daily TDF/FTC (Truvada) provides close to 100% protection against HIV infection
1 April 2012. Related: Conference reports, HIV prevention and transmission.
Risk of HIV reinfection may be similar to risk of initial HIV infection
1 April 2012. Related: Conference reports, HIV prevention and transmission.
Case report: homozygous CCR5 delta-32 protection overcome by infection with X4 virus
1 April 2012. Related: Conference reports, HIV prevention and transmission.
NICE guidance on increasing the uptake of HIV testing
1 February 2012. Related: HIV prevention and transmission.
International PrEP study (VOICE) discontinues use of tenofovir vaginal gel due to lack of efficacy
1 December 2011. Related: HIV prevention and transmission.
UK Health Protection Agency (HPA) recommends universal HIV testing in the high incidence regions of the UK
1 December 2011. Related: HIV prevention and transmission.
Orange Farm circumcision results dispel concerns about risk compensation
1 October 2011. Related: Conference reports, HIV prevention and transmission.
DSMB stops oral tenofovir monotherapy arm of VOICE PrEP study due to lack of difference compared to placebo
1 October 2011. Related: HIV prevention and transmission.
Treatment is prevention: ARV treatment in HPTN-052 reduces transmission by at least 96%: single transmission in treatment arm occurred before viral suppression
1 August 2011. Related: Conference reports, Antiretrovirals, HIV prevention and transmission.
Daily oral tenofovir/FTC PrEP reduces heterosexual transmission by 63% in the TDF2 study
1 August 2011. Related: Conference reports, Antiretrovirals, HIV prevention and transmission.
Tenofovir/FTC vs tenofovir as daily oral PrEP: preliminary results from Partners PrEP
1 August 2011. Related: Conference reports, Antiretrovirals, HIV prevention and transmission.
HPTN 052 study stopped early: significant reduction in HIV transmission from early use of HIV treatment in serodifferent partners
1 August 2011. Related: HIV prevention and transmission.
Preventive technologies, immune-based and gene therapies, and research towards a cure
14 July 2011. Related: HIV prevention and transmission, Basic science and immunology, Vaccines and microbicides.
FEM-PrEP prevention study using daily Truvada halted during enrolment: interim analysis shows similar infection rates in active and placebo arms
1 May 2011. Related: HIV prevention and transmission.
US CDC issue preliminary guidance for use of PrEP
1 February 2011. Related: HIV prevention and transmission.
Pre-exposure prophylaxis (PrEP) with tenofovir/FTC reduces sexual transmission of HIV between men at high risk: results from the iPrEx study
1 December 2010. Related: HIV prevention and transmission.
Male circumcision retains effectiveness at reducing risk of HIV infection: 54 month results
1 October 2010. Related: Conference reports, HIV prevention and transmission.
Results from the Caprisa 004 tenofovir microbicide trial
26 August 2010. Related: Conference reports, HIV prevention and transmission, Vaccines and microbicides.
Quadrivalent HPV vaccine reduces genital lesions and HPV acquisition in men
26 August 2010. Related: Conference reports, HIV prevention and transmission, Vaccines and microbicides.
Lime juice is not a microbicide: do not try at home
26 August 2010. Related: Conference reports, Women's health, HIV prevention and transmission.
Immune-based therapies and preventive technologies pipeline
1 July 2010. Related: Pipeline report, HIV prevention and transmission, Basic science and immunology, Vaccines and microbicides.
Summaries of other studies
1 June 2010. Related: Conference reports, HIV prevention and transmission.
HIV reinfection cases reported at CROI
1 June 2010. Related: Conference reports, HIV prevention and transmission, Virology.
Treatment reduces infections by over 90%: a theme that is here to stay
2 April 2010. Related: Conference reports, Antiretrovirals, HIV prevention and transmission.
Male circumcision: new data supporting protective mechanism
4 February 2010. Related: HIV prevention and transmission.
A caution for male circumcision programmes: high complication rates highlighted outside a trial setting
4 February 2010. Related: HIV prevention and transmission.
HIV reinfection reported in 10% of couples in Zambian study
26 December 2008. Related: Conference reports, HIV prevention and transmission.
Intermittent tenofovir/FTC PrEP offers monkeys some protection
30 October 2008. Related: Conference reports, HIV prevention and transmission.
Tenofovir/FTC gel protects female monkeys from SHIV
30 October 2008. Related: Conference reports, HIV prevention and transmission.
Recently infected HIV-positive Quebec residents cause more than half of new cases
30 October 2008. Related: Conference reports, HIV prevention and transmission.
Common estimate of heterosexual HIV transmission risk sometimes far too low
30 October 2008. Related: Conference reports, HIV prevention and transmission.
Implications of transmission with undetectable HIV viral load: lower limit for HIV transmission excluded from model
30 October 2008. Related: HIV prevention and transmission.
Case report of sexual transmission when viral load suppressed to <50 copies/mL
30 October 2008. Related: HIV prevention and transmission.
HIV RNA is detectable in semen in 5% patients with undetectable blood plasma viral attending fertility clinic
30 October 2008. Related: HIV prevention and transmission.
Tenofovir gel as a rectal microbicide: evidence for protection and priming of T-cell responses in the SIV challenge model
30 October 2008. Related: HIV prevention and transmission.
Genetic protection against malaria may increase susceptibility to HIV infection in people of African decent
30 October 2008. Related: HIV prevention and transmission.
US CDC issue reports of false-positive oral rapid tests in New York HIV testing programme
30 October 2008. Related: HIV prevention and transmission.
Epidemiological studies and transmission of resistance: evidence for optimism or issues with interpretation?
3 August 2006. Related: Conference reports, HIV prevention and transmission, Drug resistance.
Prevention of rectal transmission of SIV in macaques using FTC with tenofovir: FTC has independent protective effect even as monotherapy
12 May 2006. Related: Conference reports, HIV prevention and transmission.
K65R frequently emerges within 1-6 weeks of tenofovir monotherapy in macaques
12 May 2006. Related: Conference reports, HIV prevention and transmission.
A genome armed against HIV
12 May 2006. Related: Conference reports, HIV prevention and transmission.
Circumcision: a surprising benefit from an unkind cut
12 May 2006. Related: Conference reports, HIV prevention and transmission.
Topical microbicides: the real front line of HIV prevention
12 May 2006. Related: Conference reports, HIV prevention and transmission, Vaccines and microbicides.
HSV-2 suppression reduces HIV and HSV shedding
12 April 2006. Related: Conference reports, HIV prevention and transmission.
Adult male circumcision reduces transmission rates over 18 months comparable to a vaccine with 65% efficacy
14 September 2005. Related: Conference reports, HIV prevention and transmission.